These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

293 related items for PubMed ID: 4347066

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Renal failure during liver disease--The significance of endotoxins (author's transl)].
    Wilkinson SP.
    Z Gastroenterol; 1977 Nov; 15(11):663-9. PubMed ID: 339583
    [Abstract] [Full Text] [Related]

  • 23. Perinatal nephrobiology: a developmental perspective.
    Leake RD.
    Clin Perinatol; 1977 Sep; 4(2):321-49. PubMed ID: 332432
    [No Abstract] [Full Text] [Related]

  • 24. [New approaches in the pathogenesis of renal insufficiency in cirrhosis].
    Golindano CE.
    G E N; 1980 Sep; 34(1):33-44. PubMed ID: 6108900
    [Abstract] [Full Text] [Related]

  • 25. Effect of dipyridamole on kidney function in cirrhosis.
    Llach J, Ginès P, Arroyo V, Salmerón JM, Ginès A, Jiménez W, Gaya J, Rivera F, Rodés J.
    Hepatology; 1993 Jan; 17(1):59-64. PubMed ID: 8423042
    [Abstract] [Full Text] [Related]

  • 26. Renal function in pregnancy.
    Lindheimer MD, Katz AI.
    Obstet Gynecol Annu; 1972 Jan; 1():139-76. PubMed ID: 4359967
    [No Abstract] [Full Text] [Related]

  • 27. Impairment of renal function during moderate physical exercise in cirrhotic patients with ascites: relationship with the activity of neurohormonal systems.
    Saló J, Guevara M, Fernández-Esparrach G, Bataller R, Ginès A, Jimenez W, Ginès P, Rivera F, Arroyo V, Rodés J.
    Hepatology; 1997 Jun; 25(6):1338-42. PubMed ID: 9185749
    [Abstract] [Full Text] [Related]

  • 28. Hepatorenal syndrome. A review.
    Altman KA.
    Am J Gastroenterol; 1968 May; 49(5):436-9. PubMed ID: 4297522
    [No Abstract] [Full Text] [Related]

  • 29. [Angiotensin intradermoreaction in patients with liver cirrhosis in the ascitic phase. Results and interpretation in relation to the pathogenesis of the altered hydrosaline metabolism in cirrhogenic liver diseases].
    Santambrogio S, Natangelo R, Lucchelli PD.
    Minerva Med; 1966 Dec 19; 57(101):4366-71. PubMed ID: 4289384
    [No Abstract] [Full Text] [Related]

  • 30. [Pathogenesis of acute kidney failure in shock and renal circulation in man].
    Reubi F, Vorburger C, Tuckman J.
    J Urol Nephrol (Paris); 1973 Dec 19; 79(12):997-1005. PubMed ID: 4368205
    [No Abstract] [Full Text] [Related]

  • 31. [Influence of Na supplement and limitation on blood PRA, AII, ALD and renal function in patients with liver cirrhosis].
    Gu XB, Chen HK, Zhu YF, Pei H, Liu XY.
    Zhonghua Gan Zang Bing Za Zhi; 2004 Jun 19; 12(6):370. PubMed ID: 15225438
    [No Abstract] [Full Text] [Related]

  • 32. [Renal disorders in hepatic insufficiency - pathogenesis and therapy (author's transl)].
    Thiele KG.
    Leber Magen Darm; 1977 Aug 19; 7(4):263-9. PubMed ID: 895328
    [Abstract] [Full Text] [Related]

  • 33. Ascites and hepatorenal syndrome: pathogenesis and treatment strategies.
    Ginès P, Arroyo V, Rodés J.
    Adv Intern Med; 1998 Aug 19; 43():99-142. PubMed ID: 9506180
    [No Abstract] [Full Text] [Related]

  • 34. Effects of single dose of 50mg captopril in patients with liver cirrhosis and ascites.
    Lee JK, Hsieh JF, Tsai SC, Ho YJ, Kao CH.
    Hepatogastroenterology; 2000 Aug 19; 47(33):767-70. PubMed ID: 10919029
    [Abstract] [Full Text] [Related]

  • 35. Disorders of water and electrolyte metabolism in liver disease.
    Summerskill WH, Barnardo DE, Baldus WP.
    Am J Clin Nutr; 1970 Apr 19; 23(4):499-507. PubMed ID: 4914609
    [No Abstract] [Full Text] [Related]

  • 36. Systemic nitric oxide production and renal function in nonazotemic human cirrhosis: a reappraisal.
    Sansoè G, Silvano S, Mengozzi G, Smedile A, Todros L, Baronio M, Bonardi L, Rizzetto M.
    Am J Gastroenterol; 2002 Sep 19; 97(9):2383-90. PubMed ID: 12358261
    [Abstract] [Full Text] [Related]

  • 37. Pathogenesis of ascites in cirrhosis.
    Arroyo V, Badalamenti S, Ginès P.
    Minerva Med; 1987 May 31; 78(10):645-50. PubMed ID: 3587709
    [No Abstract] [Full Text] [Related]

  • 38. [Edematous diseases].
    Kinouchi T.
    Nihon Rinsho; 1979 May 31; 37(2):348-56. PubMed ID: 374794
    [No Abstract] [Full Text] [Related]

  • 39. Renal concentrating ability in cirrhosis. I. Changes associated with the clinical status and course of the disease.
    Vaamonde CA, Vaamonde LS, Morosi HJ, Klingler EL, Papper S.
    J Lab Clin Med; 1967 Aug 31; 70(2):179-94. PubMed ID: 6029052
    [No Abstract] [Full Text] [Related]

  • 40. [Water and sodium metabolism in non-compensated hepatic cirrhosis: therapeutic indications according to the Arroyo classification].
    Cavatorta F, Queirolo C, Brignole M, Zangani F.
    Clin Ter; 1980 Jan 31; 92(2):143-53. PubMed ID: 7389274
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.